Skip to main content

Advertisement

Log in

Efficacy of serum anti-mullerian hormone (AMH) levels for prediction of polycystic ovary syndrome (PCOS) and its association with clinical, biochemical and hormonal parameters

  • Original Research Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Anti-mullerian hormone (AMH) has been proposed to add significance to diagnosis of PCOS in case of ambiguity. However, variable cutoffs of AHM among PCOS women have been reported. Using case-control design, this study investigated the diagnostic threshold of serum AMH levels among age matched 113 PCOS and 75 normo-ovulatory women and its correlation with clinical, hormonal and ultrasonographic parameters.PCOS was defined as per Rotterdam criteria 2003. Results depicted the mean serum AMH level to be significantly higher in PCOS group (7.84 ± 3.67vs. 3.23 ± 1.56 ng/mL) than controls. The AMH levels were positively(p = 0.001) associated with ovarian volume (r = 0.521) as well as number of ovarian follicles(r = 0.461). Further, serum AMH levels showed a positive correlation with luteinizing hormone/follicle stimulating hormone (LH/FSH) ratio (r = 0.206, p = 0.02), but no correlation significant with age, BMI,FG score and testosterone levels. As per receiver operating characteristic (ROC) curve, cut-off was worked out to be 3.76 ng/ml with 86.7% sensitivity and 62.7% specificity. The mean level of AMH were highest among PCOS women with phenotype A (12.67 ± 3.46 ng/ml) with least among PCOS women displaying phenotype B(7.28 ± 1.60 ng/ml) where there is absence of PCOM. In conclusion, serum AMH levels are highly predictive of PCOM and high LH/FSH ratio among PCOS women and may be a potent diagnostic marker of ovarian dysfunction either alone or in conjunction with other tools.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

SBP:

systolic blood pressure.

DBP:

Diastolic blood pressure.

TSH:

thyroid stimulating hormone.

LH:

leutinizing hormone.

FSH:

follicle stimulating hormone.

AMH:

antimullerian hormone.

References

  1. Naghshband Z, Kumar L, Mandappa S, Murthy ASN, Malini SS. Visceral adiposity index and lipid accumulation product as diagnostic markers of metabolic syndrome in South Indians with polycystic ovary syndrome. J Hum Reprod Sci. 2021;14(3):234. https://doi.org/10.4103/jhrs.jhrs_12_21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Hsieh Y-C, Yang P-K, Chen M-J. Metabolic Syndrome in Polycystic Ovary Syndrome. J Reprod Infertil.2021:1–11.https://doi.org/10.1142/S2661318221500158.

  3. Kumarendran B, Sumilo D, O’Reilly MW, Toulis KA, Gokhale KM, Wijeyaratne CN, et al. Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study. Eur J Endocrinol. 2019;180(4):265–72. https://doi.org/10.1530/EJE-18-0693.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Bhide P, Dilgil M, Gudi A, Shah A, Akwaa C, Homburg R. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study. Fertil Steril. 2015;103(2):537–41. https://doi.org/10.1016/j.fertnstert.2014.10.033.

    Article  CAS  PubMed  Google Scholar 

  5. Villarroel C, Merino P, Lopez P, Eyzaguirre F, Van Velzen A, Iniguez G, et al. Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Müllerian hormone. Hum Reprod. 2011;26(10):2861–8https://doi.org/10.1093/humrep/der223.

    Article  CAS  PubMed  Google Scholar 

  6. Tata B, Mimouni NEH, Barbotin A-L, Malone SA, Loyens A, Pigny P, et al. Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat Med. 2018;24(6):834–46. https://doi.org/10.1038/s41591-018-0035-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Dumont A, Robin G, Catteau-Jonard S, Dewailly D. Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review. Reprod Biol Endocrinol. 2015;13(1):1–10. https://doi.org/10.1186/s12958-015-0134-9.

    Article  CAS  Google Scholar 

  8. Wongwananuruk T, Panichyawat N, Indhavivadhana S, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, et al. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women. Taiwan J Obstet Gynecol. 2018;57(4):499–506. https://doi.org/10.1016/j.tjog.2018.06.004.

    Article  PubMed  Google Scholar 

  9. Ahmed N, Batarfi AA, Bajouh OS, Bakhashab S. Serum anti-Müllerian hormone in the diagnosis of polycystic ovary syndrome in association with clinical symptoms. Diagnostics. 2019;9(4):136. https://doi.org/10.3390/diagnostics9040136.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Pigny P, Jonard S, Robert Y, Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndromeJ. Clin Endocrinol Metab. 2006;91(3):941–5. https://doi.org/10.1210/jc.2005-2076.

    Article  CAS  Google Scholar 

  11. Wiweko B, Maidarti M, Priangga MD, Shafira N, Fernando D, Sumapraja K, et al. Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients. J Assist Reprod Genet. 2014;31(10):1311–6. https://doi.org/10.1007/s10815-014-0300-6.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Dewailly D, Gronier H, Poncelet E, Robin G, Leroy M, Pigny P, et al. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod. 2011;26(11):3123–9. https://doi.org/10.1093/humrep/der297.

    Article  CAS  PubMed  Google Scholar 

  13. Song DK, Oh JY, Lee H, Sung YA. Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value. Korean J Intern Med. 2016;32(4):690–8. https://doi.org/10.3904/kjim.2016.038.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Tremellen K, Zander-Fox D. Serum anti‐Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan. Aust N Z J Obstet Gynaecol. 2015;55(4):384–9. https://doi.org/10.1111/ajo.12366.

    Article  PubMed  Google Scholar 

  15. Saxena U, Ramani M, Singh P. Role of AMH as diagnostic tool for polycystic ovarian syndrome. J Obstet Gynaecol India. 2018;68(2):117–22. https://doi.org/10.1007/s13224-017-1066-4.

    Article  CAS  PubMed  Google Scholar 

  16. Homburg R, Ray A, Bhide P, Gudi A, Shah A, Timms P, et al. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study. Hum Reprod. 2013;28(4):1077–83https://doi.org/10.1093/humrep/det015.

    Article  CAS  PubMed  Google Scholar 

  17. Chao K-C, Ho C-H, Shyong W-Y, Huang C-Y, Tsai S-C, Cheng H-Y, et al. Anti-Mullerian hormone serum level as a predictive marker of ovarian function in Taiwanese women. J Chin Med Assoc. 2012;75(2):70–4. https://doi.org/10.1016/j.jcma.2011.12.007.

    Article  CAS  PubMed  Google Scholar 

  18. Eilertsen TB, Vanky E, Carlsen SM. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod.2012 Aug;27(8):2494–502. https://doi.org/10.1093/humrep/des213. Epub 2012 Jun 12.

  19. Lin Y-H, Chiu W-C, Wu C-H, Tzeng C-R, Hsu C-S, Hsu M-I. Antimüllerian hormone and polycystic ovary syndrome. Fertil Steril. 2011;96(1):230–5. https://doi.org/10.1016/j.fertnstert.2011.04.003.

    Article  CAS  PubMed  Google Scholar 

  20. Li HWR, Anderson RA, Yeung WSB, Ho PC, Ng EHY. Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrheaFertil. Steril. 2011;96(3):774–9. https://doi.org/10.1016/j.fertnstert.2011.06.016.

    Article  CAS  Google Scholar 

  21. Li L, Chen X, Mo Y, Chen Y, Wenig M, Yang D. Elevated serum anti-mullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome. Wien Klin Wochenschr. 2010;122(17):519–24. https://doi.org/10.1007/s00508-010-1426-x.

    Article  CAS  PubMed  Google Scholar 

  22. Hart R, Doherty DA, Norman RJ, Franks S, Dickinson JE, Hickey M, et al. Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertil Steril. 2010;94(3):1118–21. https://doi.org/10.1016/j.fertnstert.2009.11.002.

    Article  CAS  PubMed  Google Scholar 

  23. Woo H-Y, Kim K-H, Rhee E-J, Park H, Lee M-K. Differences of the association of anti-Müllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome. Endocr J.2012;59(9):781–90. https://doi.org/10.1507/endocrj.ej12-0055.

  24. Sahmay S, Aydin Y, Oncul M, Senturk LM. Diagnosis of polycystic ovary syndrome: AMH in combination with clinical symptoms. J Assist Reprod Genet. 2014;31(2):213–20. https://doi.org/10.1007/s10815-013-0149-0.

    Article  PubMed  Google Scholar 

  25. Tehrani FR, Rahmati M, Mahboobifard F, Firouzi F, Hashemi N, Azizi F. Age-specific cut-off levels of anti-Müllerian hormone can be used as diagnostic markers for polycystic ovary syndrome. Reprod Biol Endocrinol. 2021;19(1):1–10. https://doi.org/10.1186/s12958-021-00755-8.

    Article  CAS  Google Scholar 

  26. Do Kyeong Song J-YO, Lee H, Sung Y-A. Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value. Korean J Intern Med. 2017;32(4):690. https://doi.org/10.3904/kjim.2016.038.

    Article  CAS  PubMed  Google Scholar 

  27. Yue C-Y, Lu L-k-y, Li M, Zhang Q-L, Ying C-M. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women. PLoS ONE. 2018;13(8):e0203129. https://doi.org/10.1371/journal.pone.0203129.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. de Loos AD, Hund M, Buck K, Meun C, Sillman J, Laven JS. Antimüllerian hormone to determine polycystic ovarian morphology. Fertil Steril. 2021;116(4):1149–57.https://doi.org/10.1016/j.fertnstert.2021.05.094.

    Article  CAS  Google Scholar 

  29. Liou T-H, Yang J-H, Hsieh C-H, Lee C-Y, Hsu C-S, Hsu M-I. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women. Fertil Steril. 2009;92(6):1960-5.https://doi.org/0.1016/j.fertnstert.2008.09.003.

  30. Aydoğmuş H, Kelekçi S, Elmalı F, Aydoğmuş S. Can we use serum Anti-Mullerian hormone to differentiate the diagnosis between polycystic ovary syndrome patients and healthy women with polycystic ovarian morphology and regular menstrual cycles. Saudi Med J. 2018;39(10):1011. https://doi.org/10.15537/smj.2018.10.2341.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohd. Ashraf Ganie.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sumji, S., Bhat, A., Rashid, A. et al. Efficacy of serum anti-mullerian hormone (AMH) levels for prediction of polycystic ovary syndrome (PCOS) and its association with clinical, biochemical and hormonal parameters. Ind J Clin Biochem 38, 457–465 (2023). https://doi.org/10.1007/s12291-022-01058-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-022-01058-4

Keywords

Navigation